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Abstract
Study Design: Cost analysis of a retrospectively identified cohort of patients who had undergone primary single-level lumbar
fusion at a single institution’s orthopedic or neurosurgery department.
Objective: The purpose of this article is to analyze the determinants of direct costs for single-level lumbar fusions and identify
potential areas for cost reduction.
Methods: Adult patients who underwent primary single-level lumbar fusion from fiscal years 2008 to 2012 were identified via
administrative and departmental databases and were eligible for inclusion. Patients were excluded if they underwent multiple
surgeries, had previous surgery at the same anatomic region, underwent corpectomy, kyphectomy, disc replacement, surgery for
tumor or infection, or had incomplete cost data. Demographic data, surgical data, and direct cost data in the categories of
supplies, services, room and care, and pharmacy, was collected for each patient.
Results: The cohort included 532 patients. Direct costs ranged from $8286 to $73727 (median ¼ $21781; mean ¼ $22890+
$6323). Surgical approach was an important determinant of cost. The mean direct cost was highest for the circumferential
approach and lowest for posterior instrumented spinal fusions without an interbody cage. The difference in mean direct cost
between transforaminal lumbar interbody fusions, anterior lumbar interbody fusions, and lateral transpsoas fusions was not
statistically significant. Surgical supplies accounted for 44% of direct costs. Spinal implants were the primary component of supply
costs (84.9%). Services accounted for 38% of direct costs and were highly dependent on operative time. Comorbidities were an
important contributor to variance in the cost of care as evidenced by high variance in pharmacy costs and length of stay related to
their management.
Conclusion: The costs of spinal surgeries are highly variable. Important cost drivers in our analysis included surgical approach,
implants, operating room time, and length of hospital stay. Areas of high cost and high variance offer potential targets for cost
savings and quality improvements.
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Introduction
Unsustainable health care spending in the United States has led
to an increased emphasis on cost-effectiveness and value-based
health care. Spine conditions account for a significant propor-
tion of health care spending in the United States, and the use of
health care resources for the diagnosis and treatment of these
conditions is increasing more rapidly than other areas of
health expenditures.1 Between 1997 and 2005, there was a
65% increase in health care expenditures for patients with
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self-reported back and neck problems, yet no evidence of a
corresponding improvement in self-assessed health status.1
Both increased rates of spinal surgery and increased costs of
performing these procedures have contributed to the dramatic
increase in the total expenditures for spinal surgery. The rate of
spinal fusions increased by 55% between 1979 and 1990,2 by
220% between 1990 and 2001,3 and by 73% between 1998 and
2006.4 The cost of spinal fusions has also risen. Between 1998
and 2006, the cost of surgery increased by 191% for primary
fusions and 272% for revision fusions. Rising costs, in combi-
nation with the increased rate of fusions, have led to a high
overall rate of expenditure for spinal conditions. Between 1998
and 2006, total spending increased by 408% for primary spinal
fusions and 535% for revision spinal procedures, resulting in a
total expenditure for these procedures of $29.1 billion in 2006.4
An increase in the number of patients seeking care for spine-
related conditions has been cited as the primary reason for
increased expenditures, as evidenced by a concomitant increase
in the costs of nonoperative spine care.1
In addition to the increased costs and rates of spinal
fusions, there is also a high amount of variance in the use of
lumbar fusions between the United States and other countries,
geographic regions within the United States, hospitals in the
same region, and even individual surgeons at the same hos-
pital.5,6 A study of the Medicare population between 1992 and
2003 demonstrated a 20-fold variation in the rates of lumbar
spinal fusion between the highest and lowest regional rates of
the United States.7 Some believe that this high variation of
care shows a poor consensus on surgical indications for this
procedure and suggests excessive rates of spinal fusion in
some regions.8
In our current health care economy, where there is increas-
ing competition for a limited health care dollar, it is essential to
determine whether a health care intervention adds value to
patient care—that is, whether the incremental cost for the inter-
vention is justified by an incremental improvement in health-
related benefits. Recent systematic reviews to assess value in
spine surgery have demonstrated the high value for numerous
operative interventions in spine care and have also identified
interventions that are not reliably cost-effective.9,10 Value in
spine surgery may be optimized by improving clinical out-
comes achieved and their durability, reducing complications
and the need for revision surgeries, and reducing costs. In an
effort to reduce costs, it is essential to identify the factors
driving those costs and determine areas where cost savings may
be achieved. The purpose of this article is to characterize the
determinants of direct costs and report variance in the direct
cost of care for single-level lumbar fusions.
Methods
Institutional review board approval was obtained prior to the
collection of data. Adult patients who underwent primary
single-level lumbar fusions between fiscal years 2008 and
2012 met inclusion criteria. All surgeries were performed by
1 of 10 spine surgeons from the orthopedic surgery and
neurosurgery departments at a single institution. Patients were
identified through hospital data using Current Procedural Ter-
minology codes (Appendix A). Patients were excluded if they
underwent multiple surgeries, had previous surgery at the
same level, underwent corpectomy, kyphectomy, disc
replacement surgery, surgery for tumor or infection, or had
incomplete cost data.
A major inaccuracy of using administrative codes alone was
that a significant number of cases coded as posterior spinal
fusions included a posterior-based interbody fusion (posterior
lumbar interbody fusions [PLIF] or transforaminal lumbar
interbody fusions [TLIF]). To accurately categorize many
cases, CPT codes were cross-referenced with the use of
implants from our institution’s surgical database to determine
which posterior spinal fusions were performed with an inter-
body cage, and charts were reviewed when this could not be
determined from our surgical database. The circumferential
fusion group includes only cases in which both anterior and
posterior procedures were performed on the same day. Circum-
ferential fusions staged over separate days or separate admis-
sions were not included in our analysis.
Demographic, surgical, and direct cost data was collected
for each patient and separated into four categories: supplies,
services, room and care, and pharmacy. All costs were incurred
during the course of a single hospital admission. Postdischarge
costs were not included in our analysis. Costs were identified
by direct access to medical billing data. Cost outliers in each
category were chart reviewed to improve accuracy. Direct costs
rather than charges were used for this analysis. Indirect costs
(eg, hospital administrative and facilities overhead, cost of
house staff, health information management, accounting and
billing, housekeeping, etc) were not included. Surgeon fees
were billed separately and are therefore not included in the
direct cost data. Anesthesia fees were considered a component
of the operating room costs. Operative time included the total
time the patient was in the operating room rather than time of
incision to closure.
An analysis of variance (ANOVA) was performed to com-
pare differences in costs between the 5 surgical approaches
(posterior spinal fusion [PSF], anterior lumbar interbody
fusion [ALIF], TLIF, combined approach/circumferential,
lateral). The Tukey honest significant difference (HSD)
method was used to perform pairwise comparisons between
approach types. Costs were compared by approach as well as
by cost category. These categories include: supplies, implants
(a subcategory of supplies), services, room and care, phar-
macy, and total direct costs. The differences in means for
length of stay and operating room time were also compared
between surgical approaches. Statistical analysis was per-
formed both with the inclusion and exclusion of extreme out-
liers in the categories of total direct costs (costs >$50 000;
n ¼ 1), room and care (costs >$15 000; n ¼ 2), and pharmacy
(costs >$5000; n ¼ 2), with the same conclusions achieved
in both analyses. The Statistical Analysis System (SAS)
version 9.3 was used to perform the analysis.
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Results
Seven hundred and two patients met inclusion criteria based on
CPT codes. One hundred and sixty-nine patients were excluded
based on clinical exclusion criteria and 1 was excluded for
incomplete cost data. Five hundred and thirty-two patients met
all criteria for our study. Average age was 55 years (range 19-
91 years, SD ¼ 13). Diagnoses included degenerative condi-
tions, spondylolisthesis, deformity, and trauma (Table 1). TLIF
was the most common surgical approach (48.5%), followed by
posterior spinal fusion without interbody cage (PSF; 23.3%),
circumferential (combined anterior or lateral and posterior)
fusion (13.0%), ALIF alone (12.8%), and lateral transpsoas
fusion (“lateral”—extreme lateral [XLIF]/direct lateral
[DLIF]/lumbar lateral [LLIF]) alone (2.4%). Operating room
time, hospital days, and admission to intensive care unit (ICU)
for each approach are presented in Table 2. Table 3 presents
cost categories and variance in utilization for individual com-
ponents within each category.
The direct cost of care for all surgeries ranged from $8286 to
$73727 (median ¼ $21781; mean ¼ $22890+ $6323). Man-
agement of comorbidities accounted for a large proportion of
the highest cost episodes of care creating extreme outliers in
length of stay and pharmacy categories. Circumferential
fusions had the highest direct cost of care (median ¼
$29640; mean¼ $29712+ $5419) and posterior spinal fusions
without interbody cage were the lowest cost (median¼ $18038;
mean ¼ $18 873 + $4493). Direct costs of care for each
approach are represented in Figure 1. The mean direct cost of
circumferential fusion was statistically higher than all single
approaches (PSF, lateral only, TLIF, and ALIF). For single
approach surgery, the cost of posterior spinal fusions without
interbody cage was significantly lower than all approaches
other than lateral. No significant differences in costs were
observed between the lateral approach, TLIF, and ALIF.
Table 4 presents contributions to total direct cost of each
cost category for each surgical approach. Supply costs
(median ¼ $9366) were the highest category of spending for
all fusions using an interbody cage. Supply costs included
implants, sterile supplies, and disposables used during the sur-
gery. Implants, including screws, interbody cages, recombinant
human bone morphogenetic protein (rh-BMP), and other
implants accounted for the highest proportion of supply costs.
The cost of implants and other supplies was statistically higher
in circumferential fusions compared with all single approaches
and significantly lower in posterior spinal fusions without
interbody cage compared with all other approaches. ALIF had
significantly higher implant/supply costs than TLIF. Differ-
ences in supply costs were not significant between lateral and
ALIF or lateral and TLIF.
Service costs (median ¼ $8219) were the second highest
contributor to direct cost of care for all fusions utilizing an
interbody cage, and the highest contributor for PSFs. Operative
time was the primary predictor of high service costs. Both
operative time and service costs were highest in circumferential
fusions. Differences in service costs were statistically signifi-
cant between all approaches with the exception of the lateral
approach compared with ALIF or PSF.
Room and care costs were dependent on the level of acuity
for each ward and the patient’s length of stay (range 1-19 days,
median cost ¼ $2778). The average length of stay ranged from
2.2 days for patients in the lateral group to 4.3 days for patients
undergoing circumferential fusion. Room and care costs were
significantly higher for circumferential fusions compared with
PSF, TLIF, and ALIF. Only 13 patients required ICU admis-
sion, but ICU cost was a major contributor to the total cost of
care for these patients.
Pharmacycosts contributed the least of all categories, account-
ing for 4.2% of the direct cost of care. Themedian pharmacy cost
was $739 but contained number of outliers, including 16 patients
with pharmacy costs over $2000. The highest costing case was
driven by treatment of the patient’s hemophilia, including
$53085 in pharmacy costs, primarily for factorVIII replacement.
The statistical analysis was performed both with exclusion and
inclusion of the extreme outliers with negligible impact on the
results. Pharmacy costs were statistically higher for circumferen-
tial fusions compared with PSF, TLIF, and ALIF.
Discussion
The results of our study are useful in identifying the composi-
tion of cost drivers for single-level lumbar fusions and the
variance within these components. Important cost drivers
included surgical approach, implants, operating room time, and
length of hospital stay. There were statistically significant dif-
ferences in the mean direct costs between combined circumfer-
ential fusions and single approach fusions and between
cageless fusion constructs and those using interbody cages
(lateral, TLIF, ALIF, and circumferential). Surgical implants,
especially the use of an interbody cage, contribute the highest
portion of the direct cost for instrumented fusions (Figure 1 and
Table 4). There were no differences in cost by diagnosis,
including trauma. Furthermore, diagnoses were spread across
all approach categories.
One of the most important observations of this study was the
prevalence of such high variance in costs among a relatively
homogenous cohort of patients. Our analysis shows a nine-fold
difference between the highest and lowest cost cases (coeffi-
cient of variation ¼ 29.5%) for primary single-level lumbar
fusions at the same institution. Such a wide gap is indicative
of several factors, which extend far beyond how many implants
are used. The cost of implants and osteobiologics vary
Table 1. Demographic Data.
Age, years, mean+ SD (range) 55+ 13 (19-91)
Gender, female, n (%) 294 (55.3)
Diagnosis, n (%)
Degenerative 282 (53.0)
Spondylolisthesis 211 (39.7)
Deformity 27 (5.1)
Trauma 12 (2.2)
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depending on contracted rates. With the low standard of evi-
dence required for most orthopedic devices—which come to
market through 510(k) clearances—there is a paucity of data
available to establish any correlation between the cost of an
implant and outcomes achieved. Without standardization in
cost across centers, such analysis is infeasible. While this arti-
cle does not consider clinical outcomes, it wishes to shine a
light on the issues that lack of cost transparency presents in
advancing evidence-based approaches to care.
We report median costs in our results because of the pres-
ence of significant variance including several extreme outliers
that disproportionately affect the mean cost. Highly variable
costs have been reported in the literature for other types of
spinal surgery. A study of hospital charges for single-level
anterior cervical discectomy and fusion at a single institution
found a range in total charges of $26653 to $12922011 and
several studies have reported widely variable costs for the
treatment of spinal deformity.12-14 As the health care economy
transitions toward alternative payment systems, it is imperative
that sources of variance in spine surgery be addressed such that
adequate risk stratification measures are in place and consensus
is established amongst providers on the most cost-effective
manner to deliver care. Being able to predict cost accurately
is essential to successfully driving the transition toward
bundled payment initiatives. While it is important to restrain
the trend of high expenditures in spine surgery, it would be a
hazardous interpretation of this article’s findings to believe that
the authors are advocating for pure cost-minimization. There
are indications for which more expensive procedures can be
cost-effective by improving the durability of outcomes
achieved—spending more upfront to prevent continuous inef-
ficient spending in order to bend the cost curve.
A wide range of costs also suggests high variance in the
management of patients that undergo similar procedures. The
literature has demonstrated variation between surgeons for var-
ious types of spine surgery with regard to recommendations for
surgical management, surgical approach, instrumentation, and
intraoperative services used.12,15 Areas of high cost that also
exhibit high variance in care between surgeons offer potential
targets for building consensus in order to achieve cost savings
and quality improvements.
Several intraoperative services demonstrated high variance
between practitioners. Cell saver was used in only 20.3% of
cases. Cost-effectiveness studies of cell saver in adult lumbar
spine surgery have reported mixed results.16-19 Canan et al16
found that using cell saver in single-level lumbar fusions did
not significantly reduce the need for allogenic blood transfu-
sion and was not cost-effective. Although only a minor con-
tributor to the total cost of care, the use of cell saver is an
example of a service that may not be indicated in elective
Table 3. Costs and Variability Within Cost Categories.
Category % of Total Cost
Variability
(% of Cases Utilized)
Supplies 43.8
Implants 37.2 99.1
Pedicle screws 14.3 88.3
Interbody cages 13.9 76.7
BMP 5.8 25.6
Othera 3.2 —
OR instruments 6.6 100
Services 37.6
OR costs 19.5 100
Neuromonitoring 3.9 55.6
Cell saver 0.6 20.3
Blood bank 0.6 37.6
Fluoroscopy 3.0 93.2
PT/OT 1.7 99.2
PACU 4.8 98.5
Otherb 3.5 —
Room and care 14.4
ICU 0.3 2.4
Step-down unit 0.9 5.2
Orthopedic specialty unit 11.0 87.4
Other inpatient room 2.2 5.1
Pharmacy 4.2
Thrombin 1.7 91.0
Other medications 2.5 100
Abbreviations: BMP, bone morphogenetic protein; OR, operating room;
PT/OT, physical therapist/occupational therapist; PACU, post-anesthesia care
unit; ICU, intensive care unit.
aOther implants include rods, plates, caps, crosslinks, and other bone graft
material.
b Other services include imaging, respiratory therapy, laboratory tests,
pathology, and inpatient dialysis.
Table 2. Clinical Data.
Direct Cost PSF Lateral TLIF ALIF Circumferential All Approaches
OR Time,a minutes, mean+ SD 285 + 70 240 + 85 309+ 75 235 + 85 355 + 98 299+ 84
Length of stay,b days, mean + SD 3.7+ 1.4 2.2+ 1.0 3.7+ 1.6 3.2+ 1.6 4.3+ 1.8 3.7+ 1.6
ICU admission, n (%) 4 (3.3) 1 (7.6) 4 (1.6) 3 (4.4) 1 (1.4) 13 (2.4)
Total cases, n (%) 124 (23.3) 13 (2.4) 258 (48.5) 68 (12.8) 69 (13.0) 532 (100)
Abbreviations: PSF, posterior spinal fusion; TLIF, transforaminal lumbar interbody fusion; ALIF, anterior lumbar interbody fusion; OR, operating room;
ICU, intensive care unit.
aOverall P of difference in mean OR time by analysis of variance (ANOVA): P < .0001. Pairwise comparisons showed statistically significant differences between the
following approaches: circumferential with all other approaches, ALIF/PSF, ALIF/TLIF, and lateral/TLIF.
bOverall P value of difference in mean length of stay by ANOVA: P¼ .0009. Pairwise comparisons showed statistically significant differences between the following
approaches: ALIF/circumferential, lateral/circumferential, lateral/PSF, lateral/TLIF.
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single-level lumbar fusions and is a potential area where cost
savings can be achieved by limiting its use.
Operating room time was the longest in circumferential/
combined approach fusions and was shortest in the ALIF
group. In our facility, a vascular surgeon is used for the
approach in the ALIF procedure. As such, the operating room
time in anterior procedures can be influenced by the experience
of the surgeon performing the approach. There appears to be a
relationship in the duration of operating room time and length
of hospital stay. Working closely with experienced approach
surgeons can help achieve cost savings both in the reduction of
operative time and length of stay.
The length of stay was the shortest for lateral fusions and
thus room and care costs were the smallest in this group. This
may be approach specific as lateral interbody fusions are gen-
erally considered in the “minimally invasive” category of sur-
geries, which are thought to lead to faster recovery time and
shorter hospitalizations. Interestingly, the highest ICU admis-
sion percentage was with the lateral group, however the authors
believe this is driven by outliers in a smaller number of cases
(n ¼ 13 out of 532 cases).
The overall rate of neuromonitoring (56%) in this analysis
is comparable to other rates cited in the literature.20 Evidence
for the utility of neuromonitoring is more limited for single-
level fusions compared with complex spine surgery, and
questions remain about cost-effectiveness and indications
for the use of neuromonitoring in different types of spine
surgery.21-23 High variance in the use of neuromonitoring
indicates that clearer guidelines should be outlined for the
use of this service for single-level lumbar fusions. Use of
neuronavigation or intraoperative computed tomography
scan/3D-fluoro might negate the need of neuromonitoring
especially in the setting of single level fusion, however this
adds a different cost and possibly more operative time. By not
using neuromonitoring, which often requires total intravenous
anesthesia (TIVA), the opportunity to use gas anesthesia
offers a potential for cost savings as well.
Room and care costs are highly dependent on length of stay
and level of care (ie, ICU admission). At our institution,
patients undergoing spine surgery are routinely admitted to
an orthopedic specialty unit postoperatively, which provides
more specialized nursing care at a lower cost than other
Table 4. Percentage of Total Direct Cost by Cost Category.
Cost Category PSF Lateral TLIF ALIF Circumferential All approaches Pa (ANOVA)
Supplies 34.3 54.3 43.0 53.6 48.3 43.8 <.0001
Implantsb 26.9 47.3 37.0 44.7 41.1 37.2 <.0001
Services 43.4 33.1 38.5 30.4 34.3 37.6 <.0001
Room and care 17.6 9.0 14.1 12.8 13.7 14.4 .0004
Pharmacy 4.7 3.6 4.5 3.2 3.7 4.2 .008
Total direct costs 100.00 100.00 100.00 100.00 100.00 100.00 <.0001
Abbreviations: PSF, posterior spinal fusion; TLIF, transforaminal lumbar interbody fusion; ALIF, anterior lumbar interbody fusion; ANOVA, analysis of variance.
a P value for ANOVA of the difference in mean costs between approach types.
b Implants are a subcategory of supply costs.
Figure 1. Distribution spread of total direct costs by approach type.
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hospital units. The cost structure and efficiency of care in dif-
ferent hospitals cannot be assumed to be the same. The advan-
tages of specialized orthopedic units—including shorter
lengths of stay, lower rates of transfer to the ICU, and lower
costs – have been reported in the literature at various institu-
tions.24-26 Preoperative planning and discussion of postopera-
tive disposition with patients and family prior to surgery can
also facilitate the smooth transition from postoperative care to
discharge, shortening the duration of a patients stay. Further-
more, the utilization of risk assessment and prediction tools can
further facilitate preoperative planning of postoperative care.
In our analysis, implants represented the largest proportion
of spending for all surgical approaches except cageless poster-
ior fusions. While variation in the use of implants may be low
(eg, pedicle screws were used in 88% of cases in this study), the
literature demonstrates a high variation in the costs and charges
for orthopedic implants. The total cost for pedicle screws for a
single-level fusion in our study varied in cost 6-fold (coeffi-
cient of variation ¼ 49%). In a study of 45 academic medical
centers, Pahlavan and Bederman27 found that the price of indi-
vidual spinal implants varied over 4-fold for pedicle screws and
cervical plates to nearly 8-fold for TLIF cages. Furthermore,
they found a significant relationship between higher volume of
use and lower unit cost of these implants. Multiple factors
contribute to the variable costs in spinal implants, including
differences in surgeon choices for instrumentation11,12 and var-
iation in the prices paid by hospitals for the same implant.27-29
Implant prices between hospitals vary due to confidential pur-
chasing agreements with manufacturers, which present an
obstacle to increasing cost awareness among physicians. Sim-
ilar implants have widely variable costs, as demonstrated by
differences in cost between standard pedicle screws and speci-
alty pedicle screws, including cannulated and coated screws. A
study by Streit et al28 found that orthopedic surgeons have poor
knowledge of implant costs and frequently underestimate costs.
Awareness of implant costs and uniformity of costs for similar
implants can significantly reduce cost variance for implants.
Reducing variance is an important goal for consistency of cost
and for hospital budgeting for spine surgery. Clarifying cost-
effective and clinical indications for use of interbody cages,
BMP, neuromonitoring, and cell saver might help reduce var-
iance without negatively affecting clinical outcomes.
An important limitation of this report is that we do not
consider the clinical outcome of care. The purpose of this arti-
cle is to promote cost transparency, characterize the determi-
nants of direct costs, and report variance for single-level
lumbar fusions. However, the value of interventions encom-
passes more than simply short-term cost. Porter and Lee30 sug-
gest that the medical community must shift to track outcomes
by condition over the entire cycle of care rather than by indi-
vidual interventions. In this regard, if a more expensive spine
surgery can improve health status and reduce revision surgery
rates, postoperative medication utilization, and physical ther-
apy visits more effectively and for a more prolonged period of
time than a less expensive surgery, it may actually be cost
saving to both the patient and health care system in terms of
money, time, and resource utilization. Specifically, there is
evidence that circumferential fusion may be cost saving and
value enhancing over time, despite having significantly higher
direct costs than other surgical approaches in the present study.
A cost-utility analysis by Soegaard et al31 demonstrated that
circumferential fusions resulted in improved clinical outcomes
and lower long-term costs due to a reduction in the need for
additional treatments and revision surgeries compared to pos-
terolateral fusions. In light of this, we have identified a subset
of patients from this cohort who have a minimum of 2 years of
clinical follow-up and we plan to follow-up this study with an
analysis between the costs and surgical outcomes for these
patients in a subsequent project.
The authors have also identified several other limitations to
this study. We used direct cost data from a single center to
generate this descriptive study of direct costs and variance. Our
analysis included only direct costs of the index hospital admis-
sion; indirect costs, charges, and reimbursements were not
addressed. Long-term costs, including costs associated with
additional treatments, hospital readmissions, and revision sur-
geries were not collected. Cost structures and allocation of
costs vary between institutions and thus our results may not
be widely applicable in terms of the specific distribution of
costs. However, the general concept that we present of identi-
fying areas of high cost that also demonstrate high variance is a
useful principle in targeting potential areas for cost savings and
quality improvements. Furthermore, the authors believe it is
inappropriate to focus purely on cost minimization. It is impor-
tant, however, promote a culture of cost transparency as it is
paramount to make strides in addressing many of the issues that
plague our health care economy. While the cost of care is an
important consideration for our health care system, the primary
goal of health care should be to optimize patient value. An
examination of both the incremental benefits, including
patient-centered quality of life measures and durability of out-
comes, and the costs of an intervention over time is necessary
in order to measure the true value of an intervention. Finally,
health care costs are fluid and can change year to year. The
authors did not perform a trend analysis to report changes in
costs within the study period and recognize this as a major
limitation of the study. Future studies should assess whether
the extra cost associated with a surgical approach, device, or
service is justified by an incremental improvement in outcomes
and long-term value.
Conclusion
There is a lack of consensus on the cost of care for single-level
spine fusions. This paper offers transparency into the contribu-
tors to an episode of care. There is significant variance in the
cost of care for single-level lumbar fusions. This is represen-
tative of the high degree of variance for surgical approaches to
achieve arthrodesis for lumbar spine pathologies. Implants
were the highest contributor to the total cost of care, which
increases incrementally with the use of interbody cages and
osteobiologics. Other significant contributors to the cost of care
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are service costs and length of hospital stay. Further work is
necessary to determine whether a correlation exists between
cost of care and outcomes achieved.
Appendix A
Current Procedural Terminology (CPT) Codes
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